B. Anger

961 total citations
22 papers, 744 citations indexed

About

B. Anger is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, B. Anger has authored 22 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Genetics and 5 papers in Rheumatology. Recurrent topics in B. Anger's work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Eosinophilic Disorders and Syndromes (5 papers). B. Anger is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Eosinophilic Disorders and Syndromes (5 papers). B. Anger collaborates with scholars based in Germany, United States and Spain. B. Anger's co-authors include H. Heimpel, J Lyons, CR Bartram, Johannes L. Bos, Johannes W.G. Janssen, Claus R. Bartram, H. Seliger, Félix Carbonell, Michele Baccarani and S Tura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer.

In The Last Decade

B. Anger

22 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Anger Germany 12 539 405 215 176 81 22 744
F-X Mahon France 15 496 0.9× 370 0.9× 180 0.8× 230 1.3× 91 1.1× 26 682
Teresa Davies United Kingdom 7 482 0.9× 340 0.8× 210 1.0× 149 0.8× 90 1.1× 9 719
Gill Wilson United Kingdom 11 570 1.1× 279 0.7× 257 1.2× 76 0.4× 73 0.9× 18 785
HM Kantarjian United States 10 545 1.0× 446 1.1× 163 0.8× 163 0.9× 146 1.8× 12 842
RJ Jacobson United States 11 1.0k 1.9× 915 2.3× 261 1.2× 319 1.8× 65 0.8× 16 1.2k
Jean Michel Cayuela France 10 481 0.9× 411 1.0× 132 0.6× 245 1.4× 149 1.8× 12 727
Costanza Bosi Italy 13 385 0.7× 210 0.5× 281 1.3× 98 0.6× 52 0.6× 25 630
María José Larráyoz Spain 19 417 0.8× 268 0.7× 405 1.9× 99 0.6× 148 1.8× 34 801
Michela Rondoni Italy 13 390 0.7× 230 0.6× 123 0.6× 156 0.9× 102 1.3× 42 541
Mauro Nanni Italy 16 456 0.8× 294 0.7× 402 1.9× 97 0.6× 86 1.1× 43 804

Countries citing papers authored by B. Anger

Since Specialization
Citations

This map shows the geographic impact of B. Anger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Anger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Anger more than expected).

Fields of papers citing papers by B. Anger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Anger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Anger. The network helps show where B. Anger may publish in the future.

Co-authorship network of co-authors of B. Anger

This figure shows the co-authorship network connecting the top 25 collaborators of B. Anger. A scholar is included among the top collaborators of B. Anger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Anger. B. Anger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anger, B., et al.. (2014). Onkologische Rehabilitation bei gastrointestinalen Tumorerkrankungen. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 140(4). 382–389. 5 indexed citations
2.
Lange, Julia, et al.. (2009). Wer hat größere Furcht vor einer Verkürzung der Lebensspanne: palliativ oder kurativ behandelte Krebspatienten?. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. 60(7). 255–261. 7 indexed citations
3.
Schmeiser, T., R. Arnold, Markus Wiesneth, et al.. (2008). Knochenmarktransplantation als Therapie der chronisch-myeloischen Leukämie*. DMW - Deutsche Medizinische Wochenschrift. 113(1). 6–10. 1 indexed citations
4.
Anger, B., et al.. (1992). Radon Integrals. 6 indexed citations
5.
Feickert, H. J., B. Anger, Carlos Cordon‐Cardo, & Kenneth O. Lloyd. (1990). Cell‐surface antigens of human lung tumors detected by mouse monoclonal antibodies: Definition of blood‐group‐ and non‐blood‐group‐related antigenic systems. International Journal of Cancer. 46(6). 1007–1013. 14 indexed citations
6.
Anger, B., et al.. (1990). Idiopathic myelofibrosis: a retrospective study of 103 patients.. PubMed. 75(3). 228–34. 20 indexed citations
7.
Anger, B., Tim Schmeiser, H. Heimpel, et al.. (1990). Evaluation von 196 Patienten mit chronischer myeloischer Leukämie anhand eines Standard-Prognose-Modells. Oncology Research and Treatment. 13(2). 109–114. 1 indexed citations
8.
Anger, B., J. W. G. Janssen, Hubert Schrezenmeier, et al.. (1990). Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.. PubMed. 4(4). 258–61. 80 indexed citations
9.
Anger, B., et al.. (1989). Polycythemia vera. A clinical study of 141 patients. Annals of Hematology. 59(6). 493–500. 27 indexed citations
10.
Anger, B. & H. Heimpel. (1989). Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML. Annals of Hematology. 58(6). 299–301. 8 indexed citations
11.
Anger, B., et al.. (1989). A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia. Annals of Hematology. 58(6). 275–278. 18 indexed citations
12.
Sokal, JE, GA Gomez, Michele Baccarani, et al.. (1988). Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood. 72(1). 294–298. 82 indexed citations
13.
Sokal, JE, GA Gomez, Michele Baccarani, et al.. (1988). Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood. 72(1). 294–298. 91 indexed citations
14.
Buschle, Michael, et al.. (1988). Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation.. PubMed. 2(10). 658–60. 76 indexed citations
15.
Janssen, Johannes W.G., J Lyons, B. Anger, et al.. (1987). RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.. Proceedings of the National Academy of Sciences. 84(24). 9228–9232. 192 indexed citations
16.
Kern, W., B. Anger, Winfried Haerer, E. Vanek, & H. Heimpel. (1987). [Endocarditis caused by Haemophilus parainfluenzae and Neisseria gonorrhoeae].. PubMed. 15(5). 165–72. 1 indexed citations
17.
Anger, B., Donald Bunjes, Félix Carbonell, E. Kurrle, & H. Heimpel. (1986). Treatment results of nine patients with burkitt's lymphoma. Annals of Hematology. 53(4). 279–286. 5 indexed citations
18.
Anger, B., Herbert F. Oettgen, Lloyd J. Old, et al.. (1982). Characterization of two newly established human cell lines from patients with large-cell anaplastic lung carcinoma. Cancer. 50(8). 1518–1529. 31 indexed citations
19.
Anger, B., Kenneth O. Lloyd, Herbert F. Oettgen, & Lloyd J. Old. (1982). Mouse Monoclonal IgM Antibody Against Human Lung Cancer Line SK-LC-3 with Specificity for H(O) Blood Group Antigen. Hybridoma. 1(2). 139–147. 30 indexed citations
20.
Anger, B., et al.. (1975). Mehrdimensionale Integration. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026